We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others.
Boston, United States
Founded in 2004
11-50 Employees
Working industry
Finance and Insurance
Type of company
Manufacturer
Ownership structure
Partnership
Locations
2 Locations
Number of products
3 Products
Specialised areas
Biotechnology, Venture Capital
Omega Funds offers a wide range of products and services
Product
Portfolio Company News Archives — Omega Funds
Go to product >
Product
Featured Archives — Omega Funds
Go to product >
Product
Platforms Archives — Omega Funds
Go to product >
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
United States
Overall risk estimation:
Low
The ESG Data of countries are based on public sources
Environment
D
Grade (A-E)
View details
Social
A
Grade (A-E)
View details
Governance
A
Grade (A-E)
View details
Omega Funds operates in 2 countries around the world
Get an overview of the locations of Omega Funds
Location
Country
State
City
Headquarter
United States
Massachusetts
Boston
Geneva Office
Switzerland
Geneva
Geneva
Some frequent questions that have been asked about Omega Funds
Where is Omega Funds located?
The company headquarter of Omega Funds is located in Boston, Massachusetts, United States. Omega Funds has subsidiaries in Switzerland
How many employees does Omega Funds approximately have?
As of the latest available information Omega Funds has around 11-50 employees worldwide.
When was Omega Funds founded?
Omega Funds was founded in 2004
In which industries does Omega Funds mainly work?
The company Omega Funds has it's main focus in the industries of Finance and Insurance
Check out some interesting alternative companies to Omega Funds
Neo Kuma Ventures
London, United Kingdom
1-10 Employees
2020
We provide more than just capital, working with founders from scratch to success. By working with the leading companies in this field we will advance and redefine the standard of patient care. These products were revolutionary yesterday, nascent today, and will be world changing tomorrow. Compounds, clinics and care delivery, digital therapeutics and platforms. Deep sector expertise in broad technology, med-tech, pharmaceuticals and biologics.
ALSA Ventures
London, United Kingdom
- Employees
-
We invest in biotechnology companies passionate about bringing novel therapies to patients. With a background in the pharmaceutical, biotechnology and CRO industries, our investment team brings a wealth of practical experience to portfolio, companies from spinoff to public market listing. Our investment approach is primarily focused around therapeutics. We look for novel drugs and modalities in a wide variety of disease areas, and invest across the spectrum of drug development. We are equally comfortable in company formation, as we are in participating in syndicates with co-investors.
Upstart Life Ventures
United States
- Employees
2009
We invest in opportunities such as medical devices, drug delivery systems, and diagnostics, as well as longer range investments in biopharma products and platforms. Central to our strategy is the belief that significantly more value can be created from the formation and initial management of leading edge life science companies than from traditional venture capital investing in pre-existing companies, whether at early or later stages.
Thuja Capital
Utrecht, Netherlands
1-10 Employees
2006
Investments in healthcare ventures with lasting impact for patients and society. We invest in healthcare innovation, from start-up to scale-up. We treasure daring entrepeneurs and have a keen eye for paradigm shifting ideas. We help to start, build and accelarate ventures with tranched investments, balancing risk and return. We build sustainable value by supporting the development of novel therapies in areas of high unmet medical need.
Newton Biocapital
Brussels, Belgium
11-50 Employees
2017
We are actively involved with our companies as board members, preferably as lead investor. Our mission is to mature innovation and support the growth of our portfolio companies to create value for patients, society, local ecosystems, and investors. We identify innovative solutions to chronic health conditions where the burden to both patients and reimbursement systems is high. We support projects for promising solutions in chronic health conditions, with a focus on alleviating patient and societal burdens. Drawing on our team’s scientific and medical know-how, as well as a network of experts, we seek to identify the most promising investment opportunities.
JLS Ventures
San Juan, United States
1-10 Employees
2013
Our goal is to find undiscovered venture stage companies that have a proven ability to create value. Within healthcare, we look for differentiated products supported by human data and/or IP. Life is way too short, and time way too precious to focus on things that can’t be massive.